A Study of Venetoclax in Combination With Navitoclax and Chemotherapy in Subjects With Relapsed/Refractory Acute Lymphoblastic Leukemia or Relapsed/Refractory Lymphoblastic Lymphoma

NCT03181126 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

69

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Lymphoblastic Leukemia (ALL)
Lymphoblastic Lymphoma

Interventions

DRUG: Navitoclax
DRUG: Chemotherapy
DRUG: Venetoclax

Sponsor

AbbVie